Andrew Newland (CEO) & Ian Griffiths (FD) pitch to investors at the Proactive One2One live virtual conference. ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE's proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.
22 Jan 21